ArticleMolecular therapy oncolytics2022

The NRF2-dependent transcriptional axis, XRCC5/hTERT drives tumor progression and 5-Fu insensitivity in hepatocellular carcinoma.

Tianze Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.